Although compelling studies show that HMGB1 and TLR4 play pivotal roles in the pathogenesis of cardiovascular diseases and inflammatory response, but there was no literature about HMGB1/TLR4 signaling contributes to atherogenesis induced by CUMS. Here, TLR4 is linked to cardiovascular disorder.